15:50 IST
NSE
Board Meeting Date
Pfizer Board Meeting Date
Pfizer Limited has scheduled a board meeting for July 28, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 2026.
Pfizer Ltd
- Share price
- ₹3,810.00
- Market cap
- ₹17,430 Cr
- Revenue (annual)
- ₹2,520 Cr
- Net profit (annual)
- ₹722.4 Cr
- P/E (TTM)
- 23.7×Sector 47.4×
- Promoter holding
- 63.92%+0.00% QoQ
- FII holding
- 1.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 4Financial Results 3Annual General Meeting 3Management Change 2Results Correction 1Price Movement Clarification 1Other Announcement 1Legal & Regulatory 1Dividend 1Board Meeting Outcome 1Annual Report 1
Time
4 announcements with these filters
22:10 IST
BSE
Board Meeting Date
Pfizer Board Meeting Date
Pfizer Limited has scheduled a Board Meeting for May 12, 2026, to consider and approve financial results for the quarter and year ended March 31, 2026. The board will also consider a dividend recommendation. The company's trading window remains closed until May 14, 2026.
22:00 IST
NSE
Board Meeting Date
Pfizer Board Meeting Date
Pfizer Limited has scheduled a board meeting for May 12, 2026. The board will consider and approve audited standalone financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 14, 2026.
21:57 IST
NSE
Board Meeting Date
Pfizer Board Meeting Date
Pfizer Limited has scheduled a board meeting on May 12, 2026, to consider and approve audited standalone financial results for the year ended March 31, 2026. The board will also recommend a final dividend for the financial year 2025-26. The trading window remains closed until May 14, 2026.